EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN THE TREATMENT OF CHRONIC URTICARIA

N. Gupta
{"title":"EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN THE TREATMENT OF CHRONIC URTICARIA","authors":"N. Gupta","doi":"10.51910/ijhdr.v22icf.1275","DOIUrl":null,"url":null,"abstract":"Background: Chronic urticaria is occurrence of wheals more than twice a week for a period of six weeks or longer. It is a vascular reaction of the skin characterised by the appearance of wheals, which are elevated whitish reddish plaques, generally surrounded by a red halo and associated with severe itching, stinging or burning sensations. Generally the lesions increase in frequency after adolescence, with highest incidence in persons in 3rd decade of their lives. Non- sedating anti-H1 antihistamines are the mainstay of treatment; when ineffective higher dosages are tried, though all are associated with a lot of side effects ranging from arrhythmias to osteoporosis when used for a long period. \nObjectives: The aims and objectives of the present study were to understand the clinical presentation of CU and to assess the effects of constitutional homoeopathic remedies in the treatment of chronic urticaria based on the Urticaria Activity Score (UAS), and to study their effects on the quality of life of the patients before and after treatment, using the Dermatology Life Quality Index (DLQI). \nMaterials and Methods: It was a prospective non-randomised uncontrolled observational study; sample size was 30; case taking of all the patients was done based on standard case taking proforma, consent was taken from each patient,a questionnaire of 22 points was used to elicit significant aspects of the nature of urticaria, all the patients were prescribed medicines depending on individual case; follow-up was done every 30 days from first prescription. At each visit, scoring of clinical symptoms was done with the help of UAS. Prognosis was made by comparing the different scores at each visit. Lastly, quality of life assessment was done before and after treatment using DLQI. \nResults: According to severity based on the Urticaria Activity Score, before treatment 10% patients were in mild category, 60% patients in moderate category and 30% in severe category. After treatment, 63.33% patients were in mild category and 36.67% in moderate category. The t-value was 10.56(p=0.001) for UAS. Based on DLQI, 6.67% were in large effect group, 63.33% in moderate effect group, 26.67% in small effect group and 3.33% in no effect group. \n \nKEYWORDS: Chronic Urticaria, Homoeopathic treatment, Urticaria Activity Score (UAS), Dermatology Life Quality Index(DLQI) \nConflict of interest: None \n \n ","PeriodicalId":106057,"journal":{"name":"International Journal of High Dilution Research - ISSN 1982-6206","volume":"126 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of High Dilution Research - ISSN 1982-6206","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51910/ijhdr.v22icf.1275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic urticaria is occurrence of wheals more than twice a week for a period of six weeks or longer. It is a vascular reaction of the skin characterised by the appearance of wheals, which are elevated whitish reddish plaques, generally surrounded by a red halo and associated with severe itching, stinging or burning sensations. Generally the lesions increase in frequency after adolescence, with highest incidence in persons in 3rd decade of their lives. Non- sedating anti-H1 antihistamines are the mainstay of treatment; when ineffective higher dosages are tried, though all are associated with a lot of side effects ranging from arrhythmias to osteoporosis when used for a long period. Objectives: The aims and objectives of the present study were to understand the clinical presentation of CU and to assess the effects of constitutional homoeopathic remedies in the treatment of chronic urticaria based on the Urticaria Activity Score (UAS), and to study their effects on the quality of life of the patients before and after treatment, using the Dermatology Life Quality Index (DLQI). Materials and Methods: It was a prospective non-randomised uncontrolled observational study; sample size was 30; case taking of all the patients was done based on standard case taking proforma, consent was taken from each patient,a questionnaire of 22 points was used to elicit significant aspects of the nature of urticaria, all the patients were prescribed medicines depending on individual case; follow-up was done every 30 days from first prescription. At each visit, scoring of clinical symptoms was done with the help of UAS. Prognosis was made by comparing the different scores at each visit. Lastly, quality of life assessment was done before and after treatment using DLQI. Results: According to severity based on the Urticaria Activity Score, before treatment 10% patients were in mild category, 60% patients in moderate category and 30% in severe category. After treatment, 63.33% patients were in mild category and 36.67% in moderate category. The t-value was 10.56(p=0.001) for UAS. Based on DLQI, 6.67% were in large effect group, 63.33% in moderate effect group, 26.67% in small effect group and 3.33% in no effect group. KEYWORDS: Chronic Urticaria, Homoeopathic treatment, Urticaria Activity Score (UAS), Dermatology Life Quality Index(DLQI) Conflict of interest: None  
顺势疗法药物治疗慢性荨麻疹的疗效观察
背景:慢性荨麻疹是指一周发生两次以上的荨麻疹,持续6周或更长时间。这是一种皮肤血管反应,其特征是出现小轮,小轮是升高的微白色斑块,通常被红色晕包围,并伴有严重的瘙痒、刺痛或灼烧感。一般来说,青春期后的病变频率增加,在他们生命的第三个十年中发病率最高。非镇静性抗h1抗组胺药是主要的治疗方法;当无效时,尝试更高的剂量,虽然所有的都与许多副作用有关,从心律失常到骨质疏松症,如果长期使用。目的:本研究的目的和目的是了解慢性荨麻疹的临床表现,并根据荨麻疹活动评分(UAS)评估体质顺势疗法治疗慢性荨麻疹的效果,并利用皮肤科生活质量指数(DLQI)研究其对治疗前后患者生活质量的影响。材料和方法:这是一项前瞻性非随机对照观察性研究;样本量为30人;所有患者的病例采集均基于标准的病例采集形式,每位患者均获得同意,采用22点问卷调查方式获取荨麻疹性质的重要方面,所有患者均根据具体情况处方药物;从第一次处方开始每30天随访一次。在每次访问时,临床症状评分是在UAS的帮助下完成的。通过比较每次来访的不同评分来进行预后。最后,采用DLQI进行治疗前后的生活质量评价。结果:根据荨麻疹活动度评分(Urticaria Activity Score)的严重程度,治疗前轻度占10%,中度占60%,重度占30%。治疗后,63.33%的患者为轻度,36.67%为中度。UAS的t值为10.56(p=0.001)。以DLQI为指标,大效组为6.67%,中效组为63.33%,小效组为26.67%,无效组为3.33%。关键词:慢性荨麻疹,顺势疗法治疗,荨麻疹活动评分(UAS),皮肤病生活质量指数(DLQI
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信